🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New York ➡️ Chicago! Excited to see some of our Weill Cornell Medicine @NYPHospital team members at #ASCO25, ready to connect and share insights! Weill Cornell Medicine Meyer Cancer Center WCMHemOncFellow WCM Lung Cancer WCM GI Cancer WCM GU Cancer Weill Cornell Breast Center WCM Cutaneous Oncology

The canine therapy dogs are present today #asco25 ASCO Brings a smile to so many people’s faces. Imagine if we could do this at work…

New targets in #precisiononcology spotlighted at #ASCO25: 🧬 AMG193 (MTA-PRMT5 inhibitor) shows early promise in MTAP-deleted tumors 🧪 Pan-KRAS inhibitors offer broad coverage across KRAS mutants 💡 Resistance is inevitable—but rational co-targeting strategies are emerging ASCO

🚨 Missed the #PRRT and #RadionuclideTherapy updates at #ASCO25? Don’t worry—we’ve got you covered. Check out our latest article on theranostics for pancreatic neuroendocrine tumors, now published in NPJ Precision Oncology. rdcu.be/emGpy📄npj Journals WCM GI Cancer #pnet

Looking forward to the conversation! Join me in talking about job negotiations and crafting a situation where you can thrive.

Midweek momentum in the lab: isolating & culturing T cells from KRAS-mutant pancreatic tumors 🧪 These cells will power our co-culture assays to dissect T cell-mediated tumor killing. Flow cytometry underway. #GIonc #KRAS #TumorImmunology #LabLife #CancerResearch

One of my favorite moments at #ASCO25—standing under this global display at McCormick Place. A reminder that oncology is a global effort—and every clinical insight, every T cell, every patient matters. #GIonc #ColorectalCancer #CancerResearch #ASCO2025

🚨 Promising results from Immuneering: Atebimetinib (MEK inhibitor) + chemo shows improved OS in stage IV #PancreaticCancer vs. chemo alone. Trial expanding next year—we're excited to have it open Weill Cornell Medicine! WCM GI Cancer Barbara Ma 🔗 ir.immuneering.com/news-releases/…

🚀 Kicking off our T cell isolation & culture efforts from #pancreatic tumors! Big thanks to STEMCELL Technologies for a great demo — invaluable workflow tips + expert know-how to optimize our process. Excited to push this forward! 🔬💥 #ImmunoOncology #Tcells #PancreaticCancer

T cells growing strong! 💪 First look at spleen-derived T cell cultures from our pancreatic tumor models. Excited to use these for #TCRseq & functional studies STEMCELL Technologies Weill Cornell Medicine #ImmunoOncology #PancreaticCancer #RASmutant #Tcell #CancerResearch

Honored to host CancerCast for Weill Cornell Medicine There is so much to learn and so much to talk about! Available on Apple Podcast, Spotify, or wherever you listen to podcasts! bit.ly/45BV0u0

🔥 Our T cell cultures are not just surviving — they’re killing in highly specific ways! Thrilled to see robust activity and gearing up for even more sophisticated experiments. #Immunotherapy #CancerResearch #Tcells

Big thanks to Corning Life Sciences for coming to Weill Cornell Medicine to train our team on sterility best practices as we launch new T cell co-cultures for our #immunotherapy studies! Great to have expert support as we tackle complex experiments. 🧬🧫 #CancerResearch #KRAS #contamination

🎉 Cancer Research & Treatment Fund (Cancer Research & Treatment Fund) turned 56 y/o! They continue to drive cancer research forward — even as many funding streams tighten. Grateful for CR&T’s renewed support of our work on clinically meaningful questions in #PancreaticCancer 👉 crt.org/ways-to-give/